Strong demand saw German healthcare group Fresenius sell €750m (US$833.3m) eight year debt in the bond market off its European Medium Term Note programme.
The bond has a 0.75% coupon, but priced at 99.514% to yield 0.813%.
“The proceeds will be used for general corporate purposes, including refinancing of existing financial liabilities,” the company said in a statement.
Demand, which reached €2bn at its peak, allowed initial price thoughts of mid-swaps plus 105 basis points tighten in to mid-swaps plus 85-90bp at guidance. In the end the deal went at mid-swaps plus 85bp.
Deutsche Bank and UniCredit were joint bookrunners on the deal.
At the end of November, dialysis clinic operator Fresenius Medical Care sold €1.75bn (US$1.9bn) debt in three tranches to refinance existing financial liabilities.